---
title: "12 Health Care Stocks Moving In Friday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302913182.md"
description: "During Friday's intraday session, several healthcare stocks experienced significant volatility. Top gainers included Bolt Biotherapeutics (up 58.8%), Lucid Diagnostics (up 34.26%), and Estrella Immunopharma (up 27.26%). Conversely, major losers featured Aardvark Therapeutics (down 56.5%), Lunai Bioworks (down 50.43%), and Lakewood-Amedex (down 39.9%). The report highlights these price movements alongside respective market capitalizations for the listed companies."
datetime: "2026-10-23T17:05:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302913182.md)
  - [en](https://longbridge.com/en/news/302913182.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302913182.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Friday's Intraday Session

### Gainers

-   **Bolt Biotherapeutics** (NASDAQ:BOLT) shares moved upwards by 58.8% to $6.65 during Friday's regular session. The market value of their outstanding shares is at $7.9 million.
-   **Lucid Diagnostics** (NASDAQ:LUCD) stock moved upwards by 34.26% to $0.44. The market value of their outstanding shares is at $63.6 million.
-   **Estrella Immunopharma** (NASDAQ:ESLA) stock moved upwards by 27.26% to $0.92. The company's market cap stands at $23.9 million.
-   **Streamex** (NASDAQ:STEX) stock increased by 27.14% to $0.45. The market value of their outstanding shares is at $42.9 million.
-   **Nautilus Biotechnology** (NASDAQ:NAUT) shares rose 20.57% to $3.13. The company's market cap stands at $344.8 million.
-   **NeOnc Technologies Hldgs** (NASDAQ:NTHI) shares rose 17.96% to $3.48. The company's market cap stands at $83.5 million.

### Losers

-   **Aardvark Therapeutics** (NASDAQ:AARD) stock fell 56.5% to $1.72 during Friday's regular session. The market value of their outstanding shares is at $96.5 million.
-   **Lunai Bioworks** (NASDAQ:LNAI) stock fell 50.43% to $0.23. The market value of their outstanding shares is at $2.3 million.
-   **Lakewood-Amedex** (NASDAQ:LABT) stock fell 39.9% to $0.29. The market value of their outstanding shares is at $1.1 million.
-   **Pomdoctor** (NASDAQ:POM) shares decreased by 34.98% to $1.32. The company's market cap stands at $8.3 million.
-   **Macrogenics** (NASDAQ:MGNX) stock decreased by 33.65% to $2.41. The market value of their outstanding shares is at $228.6 million.
-   **Alaunos Therapeutics** (NASDAQ:TCRT) stock decreased by 25.5% to $2.27. The market value of their outstanding shares is at $7.8 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [AARD.US](https://longbridge.com/en/quote/AARD.US.md)
- [BOLT.US](https://longbridge.com/en/quote/BOLT.US.md)
- [BSGM.US](https://longbridge.com/en/quote/BSGM.US.md)
- [ESLA.US](https://longbridge.com/en/quote/ESLA.US.md)
- [LABT.US](https://longbridge.com/en/quote/LABT.US.md)
- [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md)
- [LUCD.US](https://longbridge.com/en/quote/LUCD.US.md)
- [MGNX.US](https://longbridge.com/en/quote/MGNX.US.md)
- [NAUT.US](https://longbridge.com/en/quote/NAUT.US.md)
- [NTHI.US](https://longbridge.com/en/quote/NTHI.US.md)
- [POM.US](https://longbridge.com/en/quote/POM.US.md)
- [STEX.US](https://longbridge.com/en/quote/STEX.US.md)
- [TCRT.US](https://longbridge.com/en/quote/TCRT.US.md)

## Related News & Research

- [Aardvark Therapeutics Says Current Prader-Willi Syndrome Drug Data Insufficient](https://longbridge.com/en/news/302906209.md)
- [FDA lifts clinical hold on Aardvark Therapeutics’ ARD-101 for Prader-Willi syndrome](https://longbridge.com/en/news/302772133.md)
- [Nautilus Biotechnology (NAUT) Set to Release Earnings on Tuesday](https://longbridge.com/en/news/302386725.md)
- [NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight | NTHI Stock News](https://longbridge.com/en/news/302727059.md)
- [Aardvark Therapeutics Publishes HERO and OLE Trial Data Presentation](https://longbridge.com/en/news/302899380.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**